AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31782656
Drug: Guided self-help
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Guided self-help (low-intensity cognitive behaviour therapy including behavioural activation)
Trial: 15140756
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone replacement (GHR)
Trial: 11236299
Drug: Becotide (innovator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Becotide (innovator formulation)
Trial: 11236299
Drug: Beclate (generic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclate (generic formulation)
Trial: 2031258
Drug: Fluconazole 200
RxNorm normalized name: fluconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole 200 mg daily for 14 days
Trial: 6294175
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg twice daily (open treatment)
Trial: 30523522
Drug: Paliperidone Palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone Palmitate (PP1M) (50-150 mg equivalent)
Trial: 30523522
Drug: Oral Paliperidone
RxNorm normalized name: Paliperidone
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral Paliperidone Extended Release (ER) (6-12 mg/day)
Trial: 25277322
Drug: Solid lipid
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solid lipid curcumin (400 mg as Longvida)
Trial: 18069576
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of perindopril and indapamide
Trial: 12373472
Drug: Enoximone (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone (initial bolus 0.5 mg/kg followed by continuous infusion of 2.5 micro g/kg per minute until the 2nd postoperative day)
Trial: 22270468
Drug: Local infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local infiltration of 160 mL of levobupivacaine with adrenaline
Trial: 15704481
Drug: Phezam treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phezam treatment for 8 weeks
Trial: 11833047
Drug: Phytosterol ester-enriched
RxNorm normalized name: phytosterol esters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phytosterol ester-enriched margarine (20 g/d, 1.82 g/d of phytosterols)
Trial: 22699924
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of IV furosemide
Trial: 22699924
Drug: Bolus infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bolus infusion of IV furosemide
Trial: 20678688
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of esomeprazole 40 mg
Trial: 20678688
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of test and reference formulations
Trial: 12201829
Drug: GH replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH replacement therapy (continuous for 9 years)
Trial: 12201829
Drug: No GH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No GH replacement therapy
Trial: 7521636
Drug: APDT vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APDT vaccines (liquid and freeze-dried)
Trial: 7521636
Drug: WCPDT vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WCPDT vaccine
Trial: 2658335
Drug: 250 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml NaCl with 25 ml Ginkgo‐biloba‐extract
Trial: 19714349
Drug: Oral steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral steroid (n = 12)
Trial: 15793525
Drug: Tri-herbal combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tri-herbal combination of Eleutherococcus, Achillea millefolium, and Lamium album
Trial: 12483453
Drug: Nisoldipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine (20 mg day(-1))
Trial: 18694678
Drug: Two-compound scalp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-compound scalp formulation (calcipotriene 50 microg/g plus betamethasone 0.5 mg/g)
Trial: 26443484
Drug: 0.2% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% chlorhexidine oral rinse
Trial: 24528246
Drug: High-dose metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose metformin (50% reduction)
Trial: 21067837
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of glimepiride
Trial: 22958507
Drug: WATER therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WATER therapy program (24 sessions, 3 times/week over 8 weeks) of low-intensity exercises in a warm pool (32°C)
Trial: 22958507
Drug: WATER therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WATER therapy program
Trial: 15964291
Drug: Nestorone/ethinyl estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nestorone/ethinyl estradiol rings (all doses)
Trial: 8325044
Drug: Diclofenac (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (150 mg/day)
Trial: 10064240
Drug: Itraconazole, 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole, 2.5 mg/kg every 12 hours
Trial: 15112862
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (Penopril)
Trial: 11453894
Drug: Modified prescriptions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified prescriptions
Trial: 11453894
Drug: Non-printed prescriptions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-printed prescriptions (multivariate analysis)
Trial: 11453894
Drug: Overall correction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall correction of prescriptions in Dutch community pharmacies
Trial: 7996373
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg nebulized furosemide per kg
Trial: 7996373
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg nebulized furosemide per kg
Trial: 7996373
Drug: 0.50 mg
RxNorm normalized name: EVEROLIMUS 0.50 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.50 mg nebulized furosemide per kg
Trial: 7996373
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg nebulized furosemide per kg
Trial: 9117181
Drug: Spa therapy
RxNorm normalized name: Broda Acne Spa
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa therapy at Vichy (France) for 3 weeks
Trial: 15378139
Drug: Usual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual therapy (control group)
Trial: 3704978
Drug: Intravenous aminophylline
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous aminophylline started 30 minutes before exercise and continued throughout the 60 minute recovery period
Trial: 3704978
Drug: Intravenous aminophylline
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous aminophylline started immediately after the end of exercise
Trial: 31324081
Drug: Glimepiride-Metformin
RxNorm normalized name: Glimepiride
DrugBank: Glimepiride (DB00222)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glimepiride-Metformin
Trial: 1350696
Drug: Diltiazem (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (90 mg in three doses)
Trial: 1350696
Drug: Isradipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (5 mg in three doses)
Trial: 28933611
Drug: Medium-frequency (MG:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-frequency (MG: 40Hz x 360s)
Trial: 27488192
Drug: l-mequitazine 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-mequitazine 5.0 mg
Trial: 27488192
Drug: l-mequitazine 10
RxNorm normalized name: mequitazine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-mequitazine 10 mg
Trial: 27488192
Drug: mequitazine 10
RxNorm normalized name: mequitazine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mequitazine 10 mg
Trial: 16949482
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg clopidogrel loading dose
Trial: 16949482
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg clopidogrel loading dose
Trial: 16897237
Drug: Landiolol 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Landiolol 0.2 mg x kg(‐1)
Trial: 16897237
Drug: Landiolol 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Landiolol 0.1 mg x kg(‐1)
Trial: 8560679
Drug: Bicalutamide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicalutamide (50 mg once daily) plus LHRH analogue (goserelin acetate 3.6 mg every 28 days or leuprolide acetate 7.5 mg every 28 days)
Trial: 8560679
Drug: Flutamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (250 mg three times daily) plus LHRH analogue (goserelin acetate 3.6 mg every 28 days or leuprolide acetate 7.5 mg every 28 days)
Trial: 8560679
Drug: Bicalutamide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicalutamide (50 mg once daily)
Trial: 8708714
Drug: Flutamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (250 mg three times daily)
Trial: 1991673
Drug: Felodipine (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine (twice daily for 2 months)
Trial: 2038732
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of theophylline and terbutaline
Trial: 31248471
Drug: GSP301 (olopatadine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSP301 (olopatadine 665 μg and mometasone 25 μg)
Trial: 22737864
Drug: Stronger neo-minophagen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stronger neo-minophagen C 100 mL dissolved in 10% dextrose 250 ml once a day intravenously, combined with decoction of turtle shell for anti-fibrosis one powder daily
Trial: 19940840
Drug: HB‐AS02 (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HB‐AS02 (three doses at 0, 1, and 6 months)
Trial: 19940840
Drug: HB‐AS04 (four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HB‐AS04 (four doses at 0, 1, 2, and 6 months)
Trial: 12406033
Drug: Glyburide/metformin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide/metformin 2.5 mg/500 mg
Trial: 12406033
Drug: Glyburide/metformin 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide/metformin 5 mg/500 mg
Trial: 12406033
Drug: Glyburide 10
RxNorm normalized name: Glyburide
DrugBank: Glyburide (DB01016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide 10 mg b.i.d.
Trial: 12635468
Drug: Simvastatin 10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10 mg daily for 6 weeks, increased to 20 mg daily if LDL cholesterol goal not achieved
Trial: 12635468
Drug: Pravastatin 10
RxNorm normalized name: pravastatin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 10 mg daily for 6 weeks, increased to 20 mg daily if LDL cholesterol goal not achieved
Trial: 10337458
Drug: Topical dimethindene
RxNorm normalized name: dimethindene
DrugBank: Dimetindene (DB08801)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical dimethindene maleate (DMM) gel
Trial: 19786668
Drug: GC (gemcitabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GC (gemcitabine 1,000 mg/m(2) on days 1 and 8 and carboplatin AUC 4.5 for 21 days)
Trial: 19786668
Drug: M-CAVI (methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M-CAVI (methotrexate 30 mg/m(2) on days 1, 15, and 22; carboplatin AUC 4.5 on day 1; and vinblastine 3 mg/m(2) on days 1, 15, and 22 for 28 days)
Trial: 16202854
Drug: Felodipine +
RxNorm normalized name: Felodipine
DrugBank: Felodipine (DB01023)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felodipine + Metoprolol (F+M) 5 + 50 mg
Trial: 27881011
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy only
Trial: 10021304
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy only (specifically for stage III patients)
Trial: 17432689
Drug: Routine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine therapy plus Chinese medicinal compound for EWEPPB
Trial: 17432689
Drug: Routine Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine Western therapy alone
Trial: 15803833
Drug: Cytostatic and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytostatic and antibacterial agents
Trial: 10632027
Drug: Histamine injection
DrugBank: Histamine (DB05381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Histamine injection in area of allodynia (experimental arm)
Trial: 10632027
Drug: Histamine injection
DrugBank: Histamine (DB05381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Histamine injection in opposite forearm (control arm)
Trial: 7717489
Drug: Routine thermal
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine thermal management (circulating-water mattress set at 42 degrees C, intravenous fluid warming to 37 degrees C and passive insulation)
Trial: 31252032
Drug: Dupilumab (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dupilumab (200 mg weekly)
Trial: 22101225
Drug: Prolonged Exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged Exposure (PE) therapy delivered in-person
Trial: 10821361
Drug: Losartan (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (titrated to 50 mg once daily)
Trial: 10821361
Drug: Captopril (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (titrated to 50 mg three times daily)
Trial: 8773906
Drug: Alanine aminotransferase
RxNorm normalized name: Alanine aminotransferase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alanine aminotransferase > or = 300 U/l at entry
Trial: 30808080
Drug: udenafil 50
RxNorm normalized name: udenafil
DrugBank: Udenafil (DB06267)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: udenafil 50 mg (U50)
Trial: 30808080
Drug: udenafil 100
RxNorm normalized name: udenafil
DrugBank: Udenafil (DB06267)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: udenafil 100 mg (U100)
Trial: 22926591
Drug: Fluvoxamine (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (titrated up to 150 mg/d)
Trial: 17660033
Drug: Long-term rapamycin
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term rapamycin treatment
Trial: 16098002
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg/day (acute treatment)
Trial: 12137725
Drug: Pentoxifylline 1200
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline 1200 mg per day (3 x 400 mg) orally in addition to local therapy
Trial: 28421294
Drug: Intra-arterial chemotherapy
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial chemotherapy combined with intravesical chemotherapy (group A)
Trial: 28421294
Drug: Intravesical chemotherapy
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical chemotherapy alone (group B)
Trial: 28840277
Drug: 70 kVp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 kVp with 25 mL contrast medium (CM)
Trial: 28840277
Drug: 100 kVp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 kVp with 40 mL contrast medium (CM)
Trial: 24012432
Drug: TAP (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAP (loading dose aspirin 300 mg, clopidogrel 600 mg, cilostazol 200 mg)
Trial: 12431323
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (cisplatin-based regimens)
Trial: 2537566
Drug: Lisinopril (readministration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (readministration after 12 weeks)
Trial: 19493352
Drug: PCT-guided antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCT-guided antibiotic therapy (discontinued if PCT <1 ng/ml or dropped to 25-35% of initial value over three days)
Trial: 19493352
Drug: Standard antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antibiotic regimen (applied over eight days)
Trial: 15571523
Drug: Melatonin (6-9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (6-9 mg/day for 14 days)
Trial: 27690710
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine 300 U/mL (Gla‐300) with patient support program
Trial: 11759128
Drug: Esmolol 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol 0.4 mg/kg
Trial: 195920
Drug: Radiation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation treatment
Trial: 6356897
Drug: Labetalol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (100 to 400 mg three times a day)
Trial: 9580448
Drug: Metamizol 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metamizol 1 g
Trial: 12359036
Drug: Contingency management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contingency management + patch
Trial: 12359036
Drug: Relapse prevention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relapse prevention + patch
Trial: 10092007
Drug: Ad5 wt
RxNorm normalized name: semaglutide
DrugBank: Semaglutide (DB13928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ad5 wt vaccine
Trial: 26915026
Drug: 8.4% sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8.4% sodium bicarbonate infusion (0.5 mEq/kg/h for the first hour; 0.15 mEq/kg/h until completion of surgery)
Trial: 23061240
Drug: Hydrocodone daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocodone daily for 30 days (in smokers)
Trial: 23061240
Drug: Hydrocodone daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocodone daily for 30 days (in nonsmokers)
Trial: 17275657
Drug: Intravenous valproate
RxNorm normalized name: valproate
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous valproate infusion at doses ranging from 7.5 to 41.5 mg/kg and rates of 1.5 to 11 mg/kg per minute
Trial: 29229058
Drug: Qigong therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qigong therapy
Trial: 11795622
Drug: Medication (lofexidine‐HCl)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (lofexidine‐HCl)
Trial: 1688066
Drug: Terbutaline nebulizer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline nebulizer inhalation
Trial: 1688066
Drug: Crossover treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crossover treatment (both groups)
Trial: 7370603
Drug: Behringwerke antivenom
RxNorm normalized name: ANTIVENIN,CROTALIDAE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behringwerke antivenom (60-180 ml)
Trial: 24908656
Drug: Veliparib 25
RxNorm normalized name: veliparib
DrugBank: Veliparib (DB07232)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Veliparib 25 mg/m² b.i.d. and TMZ 135 mg/m²/d
Trial: 21926667
Drug: MEDI-534 (live,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEDI-534 (live, attenuated RSV/PIV3 chimeric virus vaccine candidate)
Trial: 17157557
Drug: Simple oral
RxNorm normalized name: Simple Oral Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple oral explanation (SP) + Single home visit (SH)
Trial: 17157557
Drug: Simple oral
RxNorm normalized name: Simple Oral Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple oral explanation (SP) + Repeated home visits (RH)
Trial: 17157557
Drug: Oral and
RxNorm normalized name: Tridate, oral and rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral and written explanation (RP) + Single home visit (SH)
Trial: 21244738
Drug: Physiological saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological saline solution (PSS)
Trial: 9609266
Drug: Oral oestriol
RxNorm normalized name: Oestriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oestriol (3 mg per day)
Trial: 30881102
Drug: Oliceridine 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oliceridine 0.1 mg
Trial: 30881102
Drug: Oliceridine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oliceridine 0.5 mg
Trial: 31162798
Drug: Gastrointestinal adverse
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gastrointestinal adverse events with Oliceridine 0.1 mg
Trial: 31162798
Drug: Gastrointestinal adverse
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gastrointestinal adverse events with Oliceridine 0.35 mg